214 filings
Page 7 of 11
8-K
glb ikumqwbodsx3umnh
11 Mar 20
Other Events
12:00am
424B5
q5kps mo5uic
10 Mar 20
Prospectus supplement for primary offering
9:26pm
8-K
lg74 c8hjlg
9 Mar 20
Other Events
6:05am
S-8
exdxum9cx06ro6tsq49h
13 Feb 20
Registration of securities for employees
12:00am
8-K
c85th
12 Feb 20
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
7:15am
8-K
ycjreigrmg nt
13 Jan 20
Results of Operations and Financial Condition
7:30am
8-K
sr7gqzzoab r0ady
7 Nov 19
Kala Pharmaceuticals Reports Third Quarter 2019 Financial Results
7:19am
8-K
5jn awzd5d
8 Aug 19
Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial
4:05pm
8-K
j90f 3vk3mtsx
6 Aug 19
Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results
7:05am
8-K
6nh1il 3l22jc
10 Jun 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
99okzr9z 14t5
9 May 19
Kala Pharmaceuticals Reports First Quarter 2019 Financial Results
7:06am
DEFA14A
sphvu6
12 Apr 19
Additional proxy soliciting materials
4:08pm
S-8
av70u6m0q81wi68ig
12 Mar 19
Registration of securities for employees
8:42am
8-K
e6u415wqr
11 Mar 19
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:56pm